In this episode of the IJGC podcast, Editor-in-Chief Dr. Pedro Ramirez is joined by Drs. Charlotte LeJeune and Frédéric Amant to discuss ICG-Guided SLN Mapping in Cervical Cancer in Pregnancy. 

Dr. Charlotte LeJeune is a clinical fellow in High-Risk Obstetrics at University Hospitals Leuven, Belgium. She is currently finalising her PhD under the supervision of Prof. Dr. Frédéric Amant, founder of the International Network on Cancer, Infertility and Pregnancy (INCIP). Her research focuses on optimising the staging and treatment of cancer during pregnancy, with a particular emphasis on cervical cancer. She is an active member of the Advisory Board on Cancer, Infertility and Pregnancy (ABCIP). Her clinical and research interests focus on improving oncological and obstetric outcomes for pregnant patients diagnosed with cancer through multidisciplinary care and international collaboration.

Frédéric Amant (MD, PhD) received his medical degree from the University of Leuven (KU Leuven), Belgium in 1992, completed his specialty training as an obstetrician/gynecologist in 1998 and his subspecialty training in gynecologic oncology in 2000. He defended his thesis on uterine sarcomas in 2002 at the KU Leuven. He is specialist at the UZ Leuven in Belgium. He is professor at the KU Leuven in Belgium and at the University of Amsterdam in the Netherlands, and honorary professor at the university of Pretoria, South Africa. Since 2024 he is council member of the European Society of Gynecologic Oncology.

Frédéric Amant heads the Gynecologic Oncology research section at the University of Leuven, Belgium and at the Netherlands Cancer Institute. In 2005 he founded the “International Network on Cancer, Infertility and Pregnancy” (INCIP)(www.cancerinpregnancy.org), and chairs this network up till now. Since 2014, INCIP also registers young women who aim to preserve their fertility. In 2021 he launched the Advisory Board Cancer Infertility Pregnancy (ABCIP) under the umbrella of INCIP. In addition, Frédéric Amant founded Trace, the tumor xenograft platform at the KU Leuven and the Fund for Innovative Research at the KU Leuven. He co-founded ENITEC, the European Network on Individualized Treatment of Endometrial Cancer. Since 2024 he is member of the research council at the KU Leuven.